PNC Managed Account Solutions’s Exact Sciences EXAS Stock Holding History

PNC Managed Account Solutions’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$30K	Buy	+243	New	+$29K	0.01%	410

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PNC Managed Account Solutions's EXAS Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in Exact Sciences (EXAS) in Q2 2021: 243 shares worth $30K. The stake represents 0.01% of the portfolio and ranks #410 among its holdings.

622 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

PNC Managed Account Solutions held 243 shares of Exact Sciences worth $30K as of Q2 2021.
Exact Sciences was a new PNC Managed Account Solutions position in Q2 2021.
Exact Sciences made up 0.01% of PNC Managed Account Solutions's portfolio in Q2 2021, its #410 holding.
622 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.